MBX Biosciences Inc

MBX remains in a Stage 2 advancing uptrend with higher highs and lows intact. Active Lockout Rally and Parabola patterns indicate urgency-driven continuation, and price is holding just above the rising 9 EMA and 21 EMA after a shallow pullback. Despite extreme overbought readings, the Lockout Rally override supports further upside extension. We will Buy Now to participate in the ongoing momentum.

• ↑Antigen revenues jumped 34% YoY in Q1, driving segment growth.
• ↑Gross margin rose to 62% after production efficiency upgrades.
• ↓Q1 revenue fell 30% YoY to $4.2 M, underscoring volatility.